JM
Jonathan L Marcus
Sr MD General Counsel

Jonathan L Marcus insider trades: Cme Group (CME) stock sales

Sr MD General Counsel, Cme Group Last trade Mar 17, 2026 11 Form 4 filings
$2.1M
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
5
Open-market trades
since 2025
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jonathan reports to the SEC

Open-market buys and sales

5 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 17, 2026CME↓ Sell10b5-1$1.0M
Mar 17, 2026CME↓ Sell10b5-1$1.1M
Sep 18, 2025CME↓ Sell10b5-1$103K
Sep 16, 2025CME↓ Sell10b5-1$97K
May 20, 2025CME↓ Sell10b5-1$108K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CME insiders

Open-market trades in the last 12 months

About Jonathan L Marcus's insider trades

Jonathan L Marcus is Sr MD General Counsel at Cme Group (CME). Since May 20, 2025, Jonathan has reported no open-market purchases and 5 sales worth $2.4M on SEC Form 4. In the last 12 months: 2 sales ($2.1M).

5 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (5 filings), shares withheld for taxes (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CME insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.